Clifford J. Woolf

Children's Hospital Boston - F.M. Kirby Neurobiology Center

United States

SCHOLARLY PAPERS

2

DOWNLOADS

235

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Nociceptor Neurons Decrease Cancer Immunosurveillance

CELL-D-20-00997
Number of pages: 38 Posted: 22 Apr 2020
University of Montreal - Department of Pharmacology and Physiology, University of Montreal - Department of Pharmacology and Physiology, Université Laval - Department of Molecular Medicine, University of Montreal - Department of Pharmacology and Physiology, Children's Hospital Boston - F.M. Kirby Neurobiology Center, Children's Hospital Boston - F.M. Kirby Neurobiology Center, Children's Hospital Boston - F.M. Kirby Neurobiology Center, Sanford Research, Cygnal Therapeutics, Cygnal Therapeutics, University of Montreal - Department of Pharmacology and Physiology, University of Montreal - Department of Pharmacology and Physiology, Children's Hospital Boston - F.M. Kirby Neurobiology Center, Massachusetts General Hospital, Universidade Federal de Santa Catarina (UFSC), University of Montreal - Department of Pharmacology and Physiology, Université Laval - Department of Molecular Medicine, McGill University - Gerald Bronfman Department of Oncology, Cygnal Therapeutics, University of Pennsylvania, Université Laval - Department of Molecular Medicine, Children's Hospital Boston - F.M. Kirby Neurobiology Center, Sanford Research and University of Montreal - Department of Pharmacology and Physiology
Downloads 232 (142,995)

Abstract:

Loading...

Nociceptor neurons, neuro-immunology, tumor innervation, melanoma, exhaustion, cytotoxic CD8 T cells, CGRP, TRPV1, QX-314, Botox.

2.

Human Amyotrophic Lateral Sclerosis Excitability Phenotype Screen: Target Discovery and Validation

CELL-STEM-CELL-D-20-00311
Number of pages: 30 Posted: 26 May 2020
Harvard University - F.M. Kirby Neurobiology Center, Harvard University - F.M. Kirby Neurobiology Center, Pfizer, Inc. - Medicine Design, Pfizer, Inc. - Medicine Design, Pfizer, Inc. - Rare Diseases Research, Pfizer, Inc. - Centers for Therapeutic Innovation (CTI), Pfizer, Inc. - Medicine Design, Pfizer Centers for Therapeutic Innovation (CTI), Pfizer, Inc. - Medicine Design, Pfizer Centers for Therapeutic Innovation (CTI), Pfizer Centers for Therapeutic Innovation (CTI), Harvard University - F.M. Kirby Neurobiology Center, Harvard University - Department of Stem Cell and Regenerative Biology, Harvard University - F.M. Kirby Neurobiology Center, Harvard University - F.M. Kirby Neurobiology Center, Harvard University - F.M. Kirby Neurobiology Center, Harvard University - F.M. Kirby Neurobiology Center, Harvard University - Department of Stem Cell and Regenerative Biology, Harvard University - F.M. Kirby Neurobiology Center, Harvard University - F.M. Kirby Neurobiology Center, Harvard University - Department of Stem Cell and Regenerative Biology and Children's Hospital Boston - F.M. Kirby Neurobiology Center
Downloads 3 (678,108)

Abstract:

Loading...

ALS, hyperexcitability, phenotypic screen, high throughput, high content, AMPA, Kv7, D2 receptor